Cancer Biopsy Market Size, Trends, Analysis, and Outlook By Product (Instruments, Kits and Consumables, Services), By Type (Tissue Biopsies, Liquid Biopsies, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prosta

Cancer Biopsy Market Size, Trends, Analysis, and Outlook By Product (Instruments, Kits and Consumables, Services), By Type (Tissue Biopsies, Liquid Biopsies, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Liver Cancers, Pancreatic Cancers, Ovarian Cancers, Others), by Region, Country, Segment, and Companies, 2024-2030

The global Cancer Biopsy market size is poised to register 11.85% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Biopsy market across By Product (Instruments, Kits and Consumables, Services), By Type (Tissue Biopsies, Liquid Biopsies, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancers, Lung Cancers, Prostate Cancers, Skin Cancers, Blood Cancers, Kidney Cancers, Liver Cancers, Pancreatic Cancers, Ovarian Cancers, Others).

The cancer biopsy market is experiencing significant expansion due to increasing incidence of cancer, advancements in tissue sampling techniques, and growing demand for precision oncology diagnostics. Cancer biopsy involves the collection and analysis of tissue samples or cells from suspicious lesions, tumors, or metastatic sites to diagnose cancer, determine tumor characteristics, and guide treatment decisions. With a focus on personalized medicine and targeted therapies, oncologists, pathologists, and diagnostic laboratories are adopting minimally invasive biopsy procedures, such as fine-needle aspiration (FNA), core needle biopsy (CNB), and liquid biopsy, to obtain tissue specimens for histological analysis, molecular profiling, and genetic testing, enabling accurate diagnosis, prognostication, and treatment planning for cancer patients, improving clinical outcomes and survival rates in oncology practice.

Cancer Biopsy Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cancer Biopsy market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cancer Biopsy survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cancer Biopsy industry.

Key market trends defining the global Cancer Biopsy demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Cancer Biopsy Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Cancer Biopsy industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cancer Biopsy companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Cancer Biopsy industry

Leading Cancer Biopsy companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cancer Biopsy companies.

Cancer Biopsy Market Study- Strategic Analysis Review

The Cancer Biopsy market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Cancer Biopsy Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Cancer Biopsy industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Cancer Biopsy Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Cancer Biopsy Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Cancer Biopsy market segments. Similarly, Strong end-user demand is encouraging Canadian Cancer Biopsy companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Cancer Biopsy market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Cancer Biopsy Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Cancer Biopsy industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Cancer Biopsy market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Cancer Biopsy Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cancer Biopsy in Asia Pacific. In particular, China, India, and South East Asian Cancer Biopsy markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Cancer Biopsy Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Cancer Biopsy Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cancer Biopsy market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cancer Biopsy.

Cancer Biopsy Market Company Profiles

The global Cancer Biopsy market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are ANGLE Plc, Becton, Dickinson and Company, Biocept Inc, Biodesix (Integrated Diagnostics), Chronix Biomedical Inc, Danaher, Epigenomics AG, Exact Sciences Corp, F. Hoffmann-La Roche Ltd, Freenome Holdings Inc, Genesystems Inc (Genesys Biolabs), GRAIL Inc, Guardant Health, HelioHealth (Laboratory for Advanced Medicine), Hologic Inc, Illumina Inc, Lucence Diagnostics Pte. Ltd, Myriad Genetics, Natera Inc, Oncimmune, Personal Genome Diagnostics Inc, Personalis Inc, Qiagen N.V., Thermo Fisher Scientific Inc

Recent Cancer Biopsy Market Developments

The global Cancer Biopsy market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Cancer Biopsy Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Product

Instruments

Kits and Consumables

Services

By Type

Tissue Biopsies

-Needle Biopsies

-Fine Needle Aspiration (FNA)

-Core Needle Biopsy (CNB)

-Surgical Biopsies

Liquid Biopsies

Others

By Application

Breast Cancer

Colorectal Cancer

Cervical Cancers

Lung Cancers

Prostate Cancers

Skin Cancers

Blood Cancers

Kidney Cancers

Liver Cancers

Pancreatic Cancers

Ovarian Cancers

Others

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

ANGLE Plc

Becton, Dickinson and Company

Biocept Inc

Biodesix (Integrated Diagnostics)

Chronix Biomedical Inc

Danaher

Epigenomics AG

Exact Sciences Corp

F. Hoffmann-La Roche Ltd

Freenome Holdings Inc

Genesystems Inc (Genesys Biolabs)

GRAIL Inc

Guardant Health

HelioHealth (Laboratory for Advanced Medicine)

Hologic Inc

Illumina Inc

Lucence Diagnostics Pte. Ltd

Myriad Genetics

Natera Inc

Oncimmune

Personal Genome Diagnostics Inc

Personalis Inc

Qiagen N.V.

Thermo Fisher Scientific Inc

Formats Available: Excel, PDF, and PPT